Physician profile
Padma Ram
NPI 1003928953
$12,392.86
in general payments reported to CMS, 2019-2025
60 companies · $2,234 in 2025
The $2,234 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $1,332 · 2021: $1,518 · 2022: $1,432 · 2023: $2,254 · 2024: $2,755 · 2025: $2,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,242.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,519.16 | 2019-2025 | |
| Novo Nordisk INC | $757.06 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $686.02 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $660.99 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $540.89 | 2019-2025 | |
| Abbott Laboratories | $509.30 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Amgen INC. | $420.39 | 2019-2025 | Otezla, Repatha, Evenity |
| Lilly USA, LLC | $396.63 | 2020-2025 | Jardiance, Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $380.06 | 2021-2025 | Spravato, Xarelto |
| Allergan, INC. | $331.98 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $317.04 | 2020-2025 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $313.87 | 2019-2023 | |
| Exact Sciences Corporation | $296.54 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $294.43 | 2019-2025 | Livalo, Seglentis, Zoryve |
| Paratek Pharmaceuticals, INC. | $245.40 | 2020-2025 | Nuzyra, Xhance |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $242.62 | 2019-2025 | Rexulti |
| Lundbeck LLC | $220.11 | 2022-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $204.96 | 2020-2025 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.46 | 2019-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Astellas Pharma US INC | $173.59 | 2019-2025 | Veozah |
| Grifols USA, LLC | $172.53 | 2019-2025 | Prolastin-C Liquid |
| Phathom Pharmaceuticals, INC. | $168.56 | 2024-2025 | Voquezna |
| Vanda Pharmaceuticals INC. | $149.34 | 2024-2025 | Fanapt, Hetlioz |
| Novartis Pharmaceuticals Corporation | $139.93 | 2019-2023 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $120.96 | 2022 | |
| Nestle Healthcare Nutrition INC. | $117.61 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $115.55 | 2020-2021 | |
| Aimmune Therapeutics, INC. | $115.43 | 2024-2025 | Zenpep |
| Xeris Pharmaceuticals, INC. | $99.48 | 2022-2024 | Keveyis, Gvoke Hypopen |
| Verona Pharma, INC. | $97.77 | 2025 | Ohtuvayre |
| Scilex Pharmaceuticals INC. | $96.48 | 2019-2024 | Ztlido |
| Axsome Therapeutics, INC. | $89.22 | 2023-2025 | Auvelity |
| Mannkind Corporation | $87.28 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $84.34 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $81.11 | 2024 | Unithroid |
| Merck Sharp & Dohme LLC | $81.05 | 2020-2024 | Verquvo, Belsomra, Steglatro |
| Corcept Therapeutics | $79.93 | 2025 | Korlym |
| Insulet Corporation | $73.58 | 2024-2025 | Omnipod |
| Sumitomo Pharma America, INC. | $69.28 | 2024-2025 | Gemtesa |
| Dexcom, INC. | $55.60 | 2021-2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $51.70 | 2025 | |
| Mylan Specialty L.P. | $51.27 | 2019-2020 | |
| Intuitive Surgical, INC. | $41.05 | 2024 | |
| Inspire Medical Systems, INC. | $38.31 | 2024-2025 | Inspire |
| Ibsa Pharma INC. | $37.94 | 2020-2025 | Tirosint, Licart, Flector |
| Cequr Corporation | $37.36 | 2025 | Cequr Simplicity |
| Horizon Therapeutics Plc | $36.47 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $35.79 | 2023-2024 | Eliquis |
| Sunovion Pharmaceuticals INC. | $35.31 | 2019 | |
| Eisai INC. | $26.18 | 2020 | |
| Baxter Healthcare | $25.94 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Neurocrine Biosciences, INC. | $25.58 | 2025 | |
| Arbor Pharmaceuticals, INC. | $24.96 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $20.14 | 2023 | Inpefa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.06 | 2025 | Caplyta |
| Assertio Therapeutics, INC. | $18.90 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.63 | 2025 | Dupixent |
| Nabriva Therapeutics, Plc | $14.83 | 2020 | |
| Radius Health, INC. | $14.60 | 2020 | |
| Tactile Systems Technology INC | $14.31 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Padma Ram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.